RSK2 protects mice against TNF-induced bone loss

C Böhm, A Derer, R Axmann… - Journal of Cell …, 2012 - journals.biologists.com
C Böhm, A Derer, R Axmann, U Hillienhoff, MM Zaiss, J Luther, C Zech, M Stock…
Journal of Cell Science, 2012journals.biologists.com
Tumor necrosis factor (TNF)-α is a key cytokine regulator of bone and mediates inflammatory
bone loss. The molecular signaling that regulates bone loss downstream of TNF-α is poorly
defined. Here, we demonstrate that inactivating the pro-osteoblastogenic ERK-activated
ribosomal S6 kinase RSK2 leads to a drastically accelerated and amplified systemic bone
loss in mice ectopically expressing TNF-α [human TNF transgenic (hTNF tg) mice]. The
phenotype is associated with a decrease in bone formation because of fewer osteoblasts as …
Tumor necrosis factor (TNF)-α is a key cytokine regulator of bone and mediates inflammatory bone loss. The molecular signaling that regulates bone loss downstream of TNF-α is poorly defined. Here, we demonstrate that inactivating the pro-osteoblastogenic ERK-activated ribosomal S6 kinase RSK2 leads to a drastically accelerated and amplified systemic bone loss in mice ectopically expressing TNF-α [human TNF transgenic (hTNFtg) mice]. The phenotype is associated with a decrease in bone formation because of fewer osteoblasts as well as a drastically increased bone destruction by osteoclasts. The molecular basis of this phenotype is a cell autonomous increased sensitivity of osteoblasts and osteocytes to TNF-induced apoptosis combined with an enhancement of their osteoclast supportive activity. Thus, RSK2 exerts a strong negative regulatory loop on TNF-induced bone loss.
journals.biologists.com